4//SEC Filing
Francois Cedric 4
Accession 0001127602-25-019413
CIK 0001492422other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 4:02 PM ET
Size
13.2 KB
Accession
0001127602-25-019413
Insider Transaction Report
Form 4
Francois Cedric
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-07-17$4.31/sh+8,997$38,777→ 351,330 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-07-17−8,997→ 100,538 totalExercise: $4.31Exp: 2027-08-20→ Common Stock (8,997 underlying) - Sale
Common Stock
2025-07-17$20.21/sh−19,725$398,735→ 331,605 total
Holdings
- 532,946(indirect: By Trust)
Common Stock
- 234,411(indirect: By Trust)
Common Stock
- 472,065(indirect: By Trust)
Common Stock
- 300,000(indirect: By Trust)
Common Stock
Footnotes (7)
- [F1]This is a scheduled exercise & sale from 10b5-1 trading plan dated March 10, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $20 - $20.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
- [F3]The securities are held by The Cedric Francois Irrevocable Trust of 2023 - 2. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023 - 2. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 - 2 except to the extent of his pecuniary interest therein.
- [F4]The securities are held by The Cedric Francois Irrevocable Trust of 2023. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
- [F5]The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
- [F6]The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.
- [F7]This option was granted on August 21, 2017 and is fully vested.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001658080
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 4:02 PM ET
- Size
- 13.2 KB